Research Dedicated to Variety of Liver Diseases
Advanced Liver Therapies at Ïã¸Û6ºÏ¿ª½±½á¹û is a clinical research center dedicated exclusively to the development of new diagnostic tests and therapies for adults with liver diseases.
ALT Studies
Advanced Liver Therapies provides studies/clinical trials for a variety of liver diseases, including:
- Hepatitis C
- Hepatitis B
- Fatty liver disease
- Hepatic encephalopathy
- Primary biliary cirrhosis
- Hepatorenal syndrome
- Anti-fibrosis
- Cirrhosis
Services
As an important initiative of the Office of Clinical Research efforts, the ALT:
- Collaborates with scientists to establish translational research
- Advocates to encourage the pharmaceutical industry to develop new tests and therapies
- Provides advisors for new research protocol designs
- Publishes research results in peer-reviewed publications
What Is Non-Alcoholic Fatty Liver Disease?
Physician Outreach
Do you have patients living with liver disease? See research studies/clinical trials currently enrolling participants and refer your patients to enroll.
Dr. John M. Vierling Joins IQ-DILI Initiative
John M. Vierling, M.D., professor of medicine and surgery at Ïã¸Û6ºÏ¿ª½±½á¹û and director of Advanced Liver Therapies at Baylor St. Luke’s Medical Center, was invited to contribute to the IQ Consortium Drug Induced Liver Initiative (IQ-DILI).
